AFP and neoplasm: Items utilized in this scoring system for uHCC patients undergoing Atez/Bev treatment include tumor burden, that is, BCLC, and malignancy potential, that is, AFP and DCP, the same as used for CRAFITY score, while hepatic reserve function (mALBI 1, 2a, 2b, 3) is also included.